Literature DB >> 16417593

Treatment of cervical dystonia with botulinum toxins.

C L Comella1, P D Thompson.   

Abstract

Botulinum toxin (BoNT) treatment has been used extensively for the treatment of cervical dystonia. In most studies, there is significant improvement following treatment for head posture and pain. The common side effects following treatment include dysphagia, dry mouth, and neck weakness. There are five brands and two serotypes of BoNT available. The dosing of each serotype and brand differs. Perhaps more importantly, each brand and serotype may differ in immunogenic potential and occurrence of secondary unresponsiveness, an issue that is currently under active investigation. Although many aspects of the technique of injection have not been adequately studied, general guidelines are available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417593     DOI: 10.1111/j.1468-1331.2006.01440.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

1.  Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.

Authors:  Roxana G Burciu; Christopher W Hess; Stephen A Coombes; Edward Ofori; Priyank Shukla; Jae Woo Chung; Nikolaus R McFarland; Aparna Wagle Shukla; Michael S Okun; David E Vaillancourt
Journal:  Hum Brain Mapp       Date:  2017-06-08       Impact factor: 5.038

2.  Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia.

Authors:  Camilla Kilbane; Jill Ostrem; Nicholas Galifianakis; Jamie Grace; Leslie Markun; Graham A Glass
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-08-28

Review 3.  Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.

Authors:  Carlos Henrique Ferreira Camargo; Lígia Cattai; Hélio Afonso Ghizoni Teive
Journal:  Toxins (Basel)       Date:  2015-06-23       Impact factor: 4.546

4.  Botulinum toxin therapy for cervical dystonia: the science of dosing.

Authors:  Virgilio Gerald H Evidente; Eric J Pappert
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-11-12

5.  A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom.

Authors:  Mireia Raluy-Callado; Sylvie Gabriel; Jérôme Dinet; Meng Wang; Radek Wasiak
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-09       Impact factor: 2.570

6.  Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study.

Authors:  Subsai Kongsaengdao; Narong Maneeton; Benchalak Maneeton
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-26       Impact factor: 2.570

7.  White Matter Changes in Cervical Dystonia Relate to Clinical Effectiveness of Botulinum Toxin Treatment.

Authors:  Anne J Blood; John K Kuster; Jeff L Waugh; Jacob M Levenstein; Trisha J Multhaupt-Buell; Lewis R Sudarsky; Hans C Breiter; Nutan Sharma
Journal:  Front Neurol       Date:  2019-04-04       Impact factor: 4.003

Review 8.  The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.

Authors:  Melani J Boyce; Alana B McCambridge; Lynley V Bradnam; Colleen G Canning; Arianne P Verhagen
Journal:  Neurol Sci       Date:  2022-05-20       Impact factor: 3.830

9.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

Review 10.  British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.

Authors:  Marie-Helene Marion; Miles Humberstone; Richard Grunewald; Sunil Wimalaratna
Journal:  Pract Neurol       Date:  2016-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.